Comparison of orally administered cannabis extract and delta-9-tetrahydrocannabinol in treating patients with cancer-related anorexia-cachexia syndrome: a multicenter, phase III, randomized, double-blind, placebo-controlled clinical trial from the C
about
The therapeutic potential of cannabis and cannabinoidsAdverse effects of medical cannabinoids: a systematic reviewPathophysiology of anorexia in the cancer cachexia syndromeAre cannabidiol and Δ(9) -tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic reviewCachexia and pancreatic cancer: are there treatment options?Marijuana Legalization: Impact on Physicians and Public HealthA user's guide to cannabinoid therapies in oncologySex differences in the cannabinoid modulation of appetite, body temperature and neurotransmission at POMC synapsesNeurobiology of inflammation-associated anorexia.Novel treatments for cancer cachexia.A review of nabilone in the treatment of chemotherapy-induced nausea and vomiting.Treatment of cachexia in oncologyTherapeutic potential of cannabinoid medicines.Marijuana and body weightOptimal management of cancer anorexia-cachexia syndrome.Cancer cachexia: mechanisms and clinical implications.Cannabidiol in humans-the quest for therapeutic targetsCancer cachexia, mechanism and treatmentNutritional interventions for cancer-induced cachexiaThe role of AMP-activated protein kinase in the androgenic potentiation of cannabinoid-induced changes in energy homeostasis.Clinical outcomes and contributors to weight loss in a cancer cachexia clinic.Cancer symptom control trials: how may we advance this field?Clinical Use of Cannabinoids for Symptom Control in Multiple Sclerosis.Cannabinoids in pancreatic cancer: correlation with survival and pain.Modulatory influences of estradiol and other anorexigenic hormones on metabotropic, Gi/o-coupled receptor function in the hypothalamic control of energy homeostasisSex differences in cannabinoid-regulated biology: A focus on energy homeostasisIntegrating cannabis into clinical cancer care.Pharmacological options for advanced cancer patients with loss of appetite and weight.Receptor subtypes and signal transduction mechanisms contributing to the estrogenic attenuation of cannabinoid-induced changes in energy homeostasis.Emerging drugs for cancer cachexia.The analgesic potential of cannabinoids.Sex differences in the cannabinoid regulation of energy homeostasisOverview of emerging pharmacotherapy in chronic heart failure.Medical marijuana in HIV-positive patients: what do we know?Medical marijuana: A panacea or scourge.Palliative care concepts in respiratory disease.Current pharmacotherapy options for cancer anorexia and cachexia.A systematic review of health-related quality of life instruments in patients with cancer cachexia.Medical marijuana for digestive disorders: high time to prescribe?Cancer cachexia syndrome: pathogenesis, diagnosis, and new therapeutic options.
P2860
Q24600806-C73BE6C2-1BF8-45B5-9586-93895C82F3A4Q24644380-EEFCB4B0-CB69-4B53-B53C-6660959A6F65Q26775294-38042E8C-5AD1-4580-841B-1DB5D1DAF45DQ27005619-84F2FF35-CF8B-4099-A64E-70D6647D1D3DQ27026558-219DA6ED-D78E-4937-A395-AC606A8A518AQ28082785-11E4C0F2-3098-4420-9563-7DFB469F79BEQ28818800-7907D65B-E9A4-4EF8-ADB3-B6AC49ACCF56Q33667914-A8AD03C7-B2C9-49C0-BC58-DA6609D46D4DQ33806456-2BD1851F-A947-4E0A-BCA0-2337D0576026Q34005616-8158D94A-BA5B-4278-B41E-4E94EEDD223FQ34013540-86CE25A9-95EC-4B82-9FF7-4427E8D23CA7Q34158188-18A1D9FB-5AB2-4FBF-84EE-164A809BA46EQ34368715-FC4BE587-BEDB-4A58-A91B-60CBF0FD42F4Q34377446-AC85F492-EA2D-47F2-8B18-18CF6E5EE784Q34417908-FFE9E1C8-261B-4180-8661-E91A742FB5BDQ34631019-ECF0159A-59C0-4975-9DD7-683E71444CCDQ34657897-3A2BD0CB-348B-4E5C-B1E6-8055FAA9B06EQ34669440-EE7D09E3-7271-4433-A9FD-1A7EFE0D8153Q35019743-287D7E24-64D5-412C-9480-EFDC6B08B136Q35178546-E32E90A6-677F-471F-9782-741DD6C40BF7Q35193902-E51F1F35-7467-453C-932C-465419056607Q35855357-5765829C-18D1-4E1C-902A-5BAF4CC65191Q36157623-3519916E-56A6-42A6-80EF-2C38ED7558F5Q36426977-345705EC-2BE3-48CD-8335-0515AD92780DQ36520628-01A52BBF-FFD1-4961-98E1-92E8FBAA42ABQ36665240-C1DC2147-8027-49DA-915D-15F084B82A86Q36685151-046D6C97-AD3C-4874-8CDC-5C1ACA3D0899Q36828134-05B3B43C-E8C1-4DBB-9F1D-F9BCE550F385Q36985061-126E02E9-1A4D-45E9-8026-FF185C34BF10Q36989913-C8A1AF68-252A-493F-8A55-93B8C4A120CCQ37057325-22E03859-4D7C-4267-9763-EA52410E15E6Q37168082-A5E902D3-80C9-42C1-A387-6CABA1A53351Q37552943-DDBA15EA-7803-498E-A4F8-E423E4F2C80EQ37642363-1263947A-314C-40F7-A76E-3AA7DDFAB276Q37723348-A647E14C-8665-4317-B514-67B28879F1ABQ37960814-A1B5D174-3160-4CB4-A589-0AE686F30907Q38052613-9BA71081-9CEE-4C7A-93FD-D0BCA29828B5Q38116773-DD00E1EC-1EB6-496C-85EE-C6FC3E494965Q38246940-C1E02551-C2F2-4BC8-B1B0-499E31589A05Q38290238-25DBFB9B-D4F8-4602-A328-6BEDFD045BB4
P2860
Comparison of orally administered cannabis extract and delta-9-tetrahydrocannabinol in treating patients with cancer-related anorexia-cachexia syndrome: a multicenter, phase III, randomized, double-blind, placebo-controlled clinical trial from the C
description
2006 nî lūn-bûn
@nan
2006 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
name
Comparison of orally administe ...... lled clinical trial from the C
@ast
Comparison of orally administe ...... lled clinical trial from the C
@en
type
label
Comparison of orally administe ...... lled clinical trial from the C
@ast
Comparison of orally administe ...... lled clinical trial from the C
@en
prefLabel
Comparison of orally administe ...... lled clinical trial from the C
@ast
Comparison of orally administe ...... lled clinical trial from the C
@en
P2093
P921
P356
P1476
Comparison of orally administe ...... lled clinical trial from the C
@en
P2093
Cannabis-In-Cachexia-Study-Group
Diana Luftner
Florian Strasser
Kurt Possinger
Marcus Reif
Martin Schnelle
Thomas Cerny
Thomas Ruhstaller
Winfried Meissner
You-Dschun Ko
P304
P356
10.1200/JCO.2005.05.1847
P407
P50
P577
2006-07-01T00:00:00Z